Prime Medicine Ownership 2024 | Who Owns Prime Medicine Now?


OverviewForecastRevenueFinancialsChart

Institutional Ownership

100.00%

Insider Ownership

26.12%

Retail Ownership

-26.12%

Institutional Holders

73.00

Prime Medicine Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ALPHABET INC.39.20%9.06%13,284,688--163,401,662,000Mar 31, 2023
FMR LLC25.13%0.01%8,517,12954,0830.64%104,760,687,000Mar 31, 2023
REDMILE GROUP, LLC5.88%1.06%1,992,843-216,507-9.80%24,511,969,000Mar 31, 2023
ARK INVESTMENT MANAGEMENT LLC5.67%0.16%1,922,277282,29317.21%23,644,007,000Mar 31, 2023
MWG MANAGEMENT LTD.5.42%15.90%1,835,876--22,581,275,000Mar 31, 2023
FIL LTD5.33%0.03%1,805,558--22,208,363,000Mar 31, 2023
BLACKROCK INC.4.47%0.00%1,514,12326,2771.77%18,623,714,000Mar 31, 2023
BAKER BROS. ADVISORS LP3.03%0.07%1,028,466--12,650,132,000Mar 31, 2023
NIKKO ASSET MANAGEMENT AMERICAS, INC.2.95%0.13%999,333511,107104.69%10,992,663,000Mar 31, 2023
SUMITOMO MITSUI TRUST HOLDINGS, INC.2.94%0.01%997,572509,346104.33%12,270,136,000Mar 31, 2023
PRICE T ROWE ASSOCIATES INC /MD/2.67%0.00%903,741-1,474,841-62.01%11,117,000Mar 31, 2023
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)2.61%0.24%885,314--10,889,362,000Mar 31, 2023
VANGUARD GROUP INC2.61%0.00%884,44611,9231.37%10,878,686,000Mar 31, 2023
CASDIN CAPITAL, LLC2.17%0.74%734,350--9,032,505,000Mar 31, 2023
CORMORANT ASSET MANAGEMENT, LP2.17%0.59%734,350--9,033,000Mar 31, 2023
ECOR1 CAPITAL, LLC1.77%0.24%600,000--7,380,000,000Mar 31, 2023
MOORE CAPITAL MANAGEMENT, LP1.48%0.13%500,000--6,150,000,000Mar 31, 2023
SAMSARA BIOCAPITAL, LLC1.39%1.19%470,304--5,784,739,000Mar 31, 2023
GREENWICH WEALTH MANAGEMENT LLC1.03%0.47%349,000349,000100.00%4,293,000Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC0.71%0.00%240,3456,0502.58%2,956,243,000Mar 31, 2023

Prime Medicine's largest institutional shareholder is ALPHABET INC., holding 39.20% of the company's total share outstanding, currently valued at $163.40B. The top 10 institutional shareholders own together 100.02% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MWG MANAGEMENT LTD.5.42%15.90%1,835,876--22,581,275,000Mar 31, 2023
ALPHABET INC.39.20%9.06%13,284,688--163,401,662,000Mar 31, 2023
OUP MANAGEMENT CO., LLC0.36%2.98%121,255--1,491,437,000Mar 31, 2023
SAMSARA BIOCAPITAL, LLC1.39%1.19%470,304--5,784,739,000Mar 31, 2023
REDMILE GROUP, LLC5.88%1.06%1,992,843-216,507-9.80%24,511,969,000Mar 31, 2023
CASDIN CAPITAL, LLC2.17%0.74%734,350--9,032,505,000Mar 31, 2023
CORMORANT ASSET MANAGEMENT, LP2.17%0.59%734,350--9,033,000Mar 31, 2023
GREENWICH WEALTH MANAGEMENT LLC1.03%0.47%349,000349,000100.00%4,293,000Mar 31, 2023
WEXFORD CAPITAL LP0.45%0.39%153,705153,705100.00%1,890,572,000Mar 31, 2023
BRANDYWINE MANAGERS, LLC0.10%0.29%32,977--405,617,000Mar 31, 2023
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)2.61%0.24%885,314--10,889,362,000Mar 31, 2023
ECOR1 CAPITAL, LLC1.77%0.24%600,000--7,380,000,000Mar 31, 2023
ARK INVESTMENT MANAGEMENT LLC5.67%0.16%1,922,277282,29317.21%23,644,007,000Mar 31, 2023
MOORE CAPITAL MANAGEMENT, LP1.48%0.13%500,000--6,150,000,000Mar 31, 2023
NIKKO ASSET MANAGEMENT AMERICAS, INC.2.95%0.13%999,333511,107104.69%10,992,663,000Mar 31, 2023
RED LIGHTHOUSE INVESTMENT MANAGEMENT, LLC0.04%0.09%14,95014,950100.00%183,885,000Mar 31, 2023
BAKER BROS. ADVISORS LP3.03%0.07%1,028,466--12,650,132,000Mar 31, 2023
FIL LTD5.33%0.03%1,805,558--22,208,363,000Mar 31, 2023
SANDIA INVESTMENT MANAGEMENT LP0.03%0.02%10,000--123,000,000Mar 31, 2023
CLARIUS GROUP, LLC0.05%0.02%16,080--197,784,000Mar 31, 2023

The largest Prime Medicine shareholder by % of total assets is MWG MANAGEMENT LTD.. The company owns 1.84M shares of Prime Medicine (PRME), representing 15.90% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
NIKKO ASSET MANAGEMENT AMERICAS, INC.2.95%0.13%999,333511,107104.69%10,992,663,000Mar 31, 2023
SUMITOMO MITSUI TRUST HOLDINGS, INC.2.94%0.01%997,572509,346104.33%12,270,136,000Mar 31, 2023
GREENWICH WEALTH MANAGEMENT LLC1.03%0.47%349,000349,000100.00%4,293,000Mar 31, 2023
ARK INVESTMENT MANAGEMENT LLC5.67%0.16%1,922,277282,29317.21%23,644,007,000Mar 31, 2023
WEXFORD CAPITAL LP0.45%0.39%153,705153,705100.00%1,890,572,000Mar 31, 2023
BANK OF AMERICA CORP /DE/0.44%0.00%150,267102,908217.29%1,848,284,000Mar 31, 2023
STATE STREET CORP0.56%0.00%189,42874,58264.94%2,329,964,000Mar 31, 2023
FMR LLC25.13%0.01%8,517,12954,0830.64%104,760,687,000Mar 31, 2023
SWISS NATIONAL BANK0.12%0.00%41,90041,900100.00%515,370,000Mar 31, 2023
JUMP FINANCIAL, LLC0.10%0.02%32,50032,500100.00%399,750,000Mar 31, 2023
PANAGORA ASSET MANAGEMENT INC0.10%0.00%32,19732,197100.00%396,023,000Mar 31, 2023
BLACKROCK INC.4.47%0.00%1,514,12326,2771.77%18,623,714,000Mar 31, 2023
CUBIST SYSTEMATIC STRATEGIES, LLC0.06%0.00%19,66318,5391649.38%241,855,000Mar 31, 2023
STATE OF WISCONSIN INVESTMENT BOARD0.05%0.00%17,99917,999100.00%221,388,000Mar 31, 2023
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM0.06%0.00%20,96716,823405.96%257,894,000Mar 31, 2023
RED LIGHTHOUSE INVESTMENT MANAGEMENT, LLC0.04%0.09%14,95014,950100.00%183,885,000Mar 31, 2023
CAPSTONE INVESTMENT ADVISORS, LLC0.04%0.00%14,55114,551100.00%178,977,000Mar 31, 2023
JANUS HENDERSON GROUP PLC0.04%0.00%14,09114,091100.00%173,111,000Mar 31, 2023
CREDIT SUISSE AG/0.04%0.00%14,70513,9051738.13%180,872,000Mar 31, 2023
MORGAN STANLEY0.10%-33,38512,99663.74%410,636,000Mar 31, 2023

As of Mar 31 2023, Prime Medicine's largest institutional buyer is NIKKO ASSET MANAGEMENT AMERICAS, INC.. The company purchased 511.11K stocks of PRME, valued at $10.99B.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PRICE T ROWE ASSOCIATES INC /MD/2.67%0.00%903,741-1,474,841-62.01%11,117,000Mar 31, 2023
REDMILE GROUP, LLC5.88%1.06%1,992,843-216,507-9.80%24,511,969,000Mar 31, 2023
CAAS CAPITAL MANAGEMENT LP----89,331-100.00%-Mar 31, 2023
GHISALLO CAPITAL MANAGEMENT LLC----70,000-100.00%-Mar 31, 2023
POINT72 MIDDLE EAST FZE----37,609-100.00%-Mar 31, 2023
WALLEYE CAPITAL LLC----30,000-100.00%-Mar 31, 2023
LMR PARTNERS LLP----17,760-100.00%-Mar 31, 2023
LEVIN CAPITAL STRATEGIES, L.P.----10,585-100.00%-Mar 31, 2023
ROYAL BANK OF CANADA0.00%-590-957-61.86%7,000,000Mar 31, 2023
PENSERRA CAPITAL MANAGEMENT LLC0.02%0.00%7,000-570-7.53%86,000Mar 31, 2023
AMALGAMATED BANK0.00%0.00%1,264-303-19.34%16,000Mar 31, 2023
FIRST HORIZON ADVISORS, INC.0.01%0.00%1,698-115-6.34%20,885,000Mar 31, 2023
MWG MANAGEMENT LTD.5.42%15.90%1,835,876--22,581,275,000Mar 31, 2023
ALPHABET INC.39.20%9.06%13,284,688--163,401,662,000Mar 31, 2023
OUP MANAGEMENT CO., LLC0.36%2.98%121,255--1,491,437,000Mar 31, 2023
SAMSARA BIOCAPITAL, LLC1.39%1.19%470,304--5,784,739,000Mar 31, 2023
CASDIN CAPITAL, LLC2.17%0.74%734,350--9,032,505,000Mar 31, 2023
CORMORANT ASSET MANAGEMENT, LP2.17%0.59%734,350--9,033,000Mar 31, 2023
BRANDYWINE MANAGERS, LLC0.10%0.29%32,977--405,617,000Mar 31, 2023
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)2.61%0.24%885,314--10,889,362,000Mar 31, 2023

As of Mar 31 2023, Prime Medicine's biggest institutional seller is PRICE T ROWE ASSOCIATES INC /MD/. The company sold -1.47M shares of PRME, valued at $11.12M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
GREENWICH WEALTH MANAGEMENT LLC1.03%0.47%349,000349,000100.00%4,293,000Mar 31, 2023
WEXFORD CAPITAL LP0.45%0.39%153,705153,705100.00%1,890,572,000Mar 31, 2023
SWISS NATIONAL BANK0.12%0.00%41,90041,900100.00%515,370,000Mar 31, 2023
JUMP FINANCIAL, LLC0.10%0.02%32,50032,500100.00%399,750,000Mar 31, 2023
PANAGORA ASSET MANAGEMENT INC0.10%0.00%32,19732,197100.00%396,023,000Mar 31, 2023
STATE OF WISCONSIN INVESTMENT BOARD0.05%0.00%17,99917,999100.00%221,388,000Mar 31, 2023
RED LIGHTHOUSE INVESTMENT MANAGEMENT, LLC0.04%0.09%14,95014,950100.00%183,885,000Mar 31, 2023
CAPSTONE INVESTMENT ADVISORS, LLC0.04%0.00%14,55114,551100.00%178,977,000Mar 31, 2023
JANUS HENDERSON GROUP PLC0.04%0.00%14,09114,091100.00%173,111,000Mar 31, 2023
MILLENNIUM MANAGEMENT LLC0.03%0.00%10,75910,759100.00%132,000Mar 31, 2023
WELLS FARGO & COMPANY/MN0.01%-1,9361,936100.00%23,813,000Mar 31, 2023
LAZARD ASSET MANAGEMENT LLC0.00%-1,5211,521100.00%18,000Mar 31, 2023
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC0.00%-1,1511,151100.00%14,157,000Mar 31, 2023
TCI WEALTH ADVISORS, INC.0.00%0.00%231231100.00%2,842,000Mar 31, 2023
FEDERATED HERMES, INC.0.00%-4545100.00%554,000Mar 31, 2023

Prime Medicine's largest new institutional shareholder by number of shares is GREENWICH WEALTH MANAGEMENT LLC, purchased 349.00K shares, valued at $4.29M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CAAS CAPITAL MANAGEMENT LP----89,331-100.00%-Mar 31, 2023
GHISALLO CAPITAL MANAGEMENT LLC----70,000-100.00%-Mar 31, 2023
POINT72 MIDDLE EAST FZE----37,609-100.00%-Mar 31, 2023
WALLEYE CAPITAL LLC----30,000-100.00%-Mar 31, 2023
LMR PARTNERS LLP----17,760-100.00%-Mar 31, 2023
LEVIN CAPITAL STRATEGIES, L.P.----10,585-100.00%-Mar 31, 2023

Prime Medicine's largest sold out institutional shareholder by shares sold is CAAS CAPITAL MANAGEMENT LP, sold -89.33K shares, valued at -, as of undefined.

Prime Medicine Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
Kelly Strategic ETF Trust0.79%21,546--Feb 29, 2024
Ark Venture Fund0.37%34,8914,37514.34%Jan 31, 2024
T. Rowe Price New Horizons Fund, Inc.0.33%1,631,137185,39112.82%Mar 31, 2024
Ark ETF Trust0.31%2,522,247-182,417-6.74%Jan 31, 2024
T. Rowe Price Small-Cap Stock Fund, Inc.0.20%742,306742,306-Mar 31, 2024
BlackRock Health Sciences Trust II0.16%412,139--Mar 31, 2024
T. Rowe Price Small-Cap Value Fund, Inc.0.10%801,678801,678-Mar 31, 2024
ROYCE MICRO-CAP TRUST, INC.0.10%46,2146,37716.01%Mar 31, 2024
BlackRock Health Sciences Trust0.09%22,929--Mar 31, 2024
T. Rowe Price Health Sciences Fund, Inc.0.08%276,452-24,554-8.16%Mar 31, 2024
VANGUARD VALLEY FORGE FUNDS0.05%28,442--Mar 31, 2024
T. Rowe Price Equity Funds, Inc.0.03%346,417346,417-Mar 31, 2024
Listed Funds Trust0.02%85,18310,15313.53%Mar 31, 2024
T. Rowe Price Equity Series, Inc.0.01%23,4219,16664.30%Mar 31, 2024
VANGUARD INDEX FUNDS0.01%5,305,4421,039,96224.38%Mar 31, 2024
QUANTITATIVE MASTER SERIES LLC0.01%72,268--Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%6,120--Mar 31, 2024
TIAA SEPARATE ACCOUNT VA 10.00%1,074--Mar 31, 2024
SCHWAB CAPITAL TRUST0.00%110,228--Jan 31, 2024
Investment Managers Series Trust II0.00%31,683-11,157-26.04%Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%45,39316,48257.01%Mar 31, 2024
Calvert Variable Products, Inc.0.00%3,901--Mar 31, 2024
Principal Exchange-Traded Funds0.00%12,314-1,014-7.61%Mar 31, 2024
FIDELITY SELECT PORTFOLIOS0.00%53,800--Feb 29, 2024
BlackRock ETF Trust0.00%730263.69%Jan 31, 2024
Direxion Shares ETF Trust0.00%101,265--Jan 31, 2024
Managed Portfolio Series0.00%13,77413,774-Mar 31, 2024
FIDELITY COVINGTON TRUST0.00%10,339--Jan 31, 2024
Global X Funds0.00%18,871--Jan 31, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%1,999--Mar 31, 2024
Voya VARIABLE PORTFOLIOS INC0.00%12,906-3,254-20.14%Mar 31, 2024
CLEARWATER INVESTMENT TRUST0.00%2,4052,405-Mar 28, 2024
TIAA-CREF LIFE FUNDS0.00%667--Mar 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%13,500--Mar 31, 2024
T. Rowe Price Index Trust, Inc.0.00%2,5411807.62%Mar 31, 2024
NORTHERN FUNDS0.00%16,045-474-2.87%Mar 28, 2024
THRIVENT SERIES FUND INC0.00%11,216--Mar 28, 2024
iSHARES TRUST0.00%1,681,313-55,799-3.21%Mar 31, 2024
EQ ADVISORS TRUST0.00%116,0512,8002.47%Mar 31, 2024
RYDEX SERIES FUNDS0.00%360--Dec 31, 2023
HC CAPITAL TRUST0.00%2,301--Mar 31, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%61,85942,280215.95%Mar 31, 2024
BLACKROCK FUNDS0.00%360,982--Feb 29, 2024
PENN SERIES FUNDS INC0.00%1,500--Mar 28, 2024
ALLSPRING MASTER TRUST0.00%3,067--Feb 29, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%5,948--Mar 31, 2024
RYDEX DYNAMIC FUNDS0.00%179--Dec 31, 2023
NATIONWIDE MUTUAL FUNDS0.00%4,075-618-13.17%Jan 31, 2024
TIAA-CREF FUNDS0.00%85,602--Jan 31, 2024
SPDR SERIES TRUST0.00%1,034,455--Mar 31, 2024
ProFunds0.00%308-24-7.23%Mar 31, 2024
AMERICAN CENTURY ETF TRUST0.00%2,472--Feb 29, 2024
RYDEX VARIABLE TRUST0.00%24--Dec 31, 2023
USAA MUTUAL FUNDS TRUST0.00%4,49074819.99%Jan 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%34,1344,83116.49%Mar 31, 2024
Brighthouse Funds Trust II0.00%13,523--Mar 31, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%33,200--Mar 31, 2024
SUNAMERICA SERIES TRUST0.00%4,482-18-0.40%Jan 31, 2024
J.P. Morgan Exchange-Traded Fund Trust0.00%5,316--Jan 31, 2024
PACIFIC SELECT FUND0.00%29,289-241-0.82%Mar 31, 2024
Blackstone Alternative Investment Funds0.00%900800800.00%Mar 31, 2024
Bridge Builder Trust0.00%29,7581760.59%Mar 31, 2024
MASSMUTUAL SELECT FUNDS0.00%5,8481,40831.71%Dec 31, 2023
FIDELITY SALEM STREET TRUST0.00%19,7562,50914.55%Mar 31, 2024
ETF Series Solutions0.00%64--Jan 31, 2024
BlackRock Variable Series Funds, Inc.0.00%4,866--Mar 31, 2024
Advisors' Inner Circle Fund III0.00%1023347.83%Jan 31, 2024
PRINCIPAL FUNDS, INC.0.00%4,9611,05126.88%Jan 31, 2024
John Hancock Funds II0.00%11,330-3,111-21.54%Feb 29, 2024

Prime Medicine's largest mutual fund holder by % of total assets is "Kelly Strategic ETF Trust", owning 21.55K shares, compromising 0.79% of its total assets.

Prime Medicine Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 237312.31%
31 Dec, 2265-
30 Sep, 19--100.00%
30 Jun, 194-
31 Mar, 194-20.00%
31 Dec, 18525.00%
30 Sep, 18433.33%
30 Jun, 183-
31 Mar, 18350.00%
31 Dec, 172-
30 Sep, 172-33.33%
30 Jun, 17350.00%
31 Mar, 172-60.00%
31 Dec, 16525.00%
30 Sep, 164-
30 Jun, 16433.33%
31 Mar, 16350.00%
31 Dec, 152-

As of 31 Mar 23, 73 institutions are holding Prime Medicine's shares, representing an increase of 12.31% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 2341,738,5751.01%
31 Dec, 2241,322,385-
30 Sep, 19--100.00%
30 Jun, 1953,03225.62%
31 Mar, 1942,21753.33%
31 Dec, 1827,533-47.50%
30 Sep, 1852,447484.11%
30 Jun, 188,979-54.07%
31 Mar, 1819,5502191.91%
31 Dec, 17853-92.71%
30 Sep, 1711,697-15.94%
30 Jun, 1713,915-38.54%
31 Mar, 1722,640-66.62%
31 Dec, 1667,833114.69%
30 Sep, 1631,5969.49%
30 Jun, 1628,85882.95%
31 Mar, 1615,77421.15%
31 Dec, 1513,020-

Prime Medicine (PRME) has 41.74M shares outstanding as of 31 Mar 23, up 1.01% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 23100.00%-
31 Dec, 22100.00%-
30 Sep, 19--
30 Jun, 19--
31 Mar, 19--
31 Dec, 18--
30 Sep, 18--
30 Jun, 18--
31 Mar, 18--
31 Dec, 17--
30 Sep, 17--
30 Jun, 17--
31 Mar, 17--
31 Dec, 16--
30 Sep, 16--
30 Jun, 16--
31 Mar, 16--
31 Dec, 15--

As of 31 Mar 23, Prime Medicine is held by 100.00% institutional shareholders, representing a 0.00% growth compared to 31 Dec 22.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 2329-
31 Dec, 22--
30 Sep, 19--100.00%
30 Jun, 192-
31 Mar, 19--100.00%
31 Dec, 182100.00%
30 Sep, 181-
30 Jun, 18--
31 Mar, 18--
31 Dec, 17--
30 Sep, 17--100.00%
30 Jun, 171-
31 Mar, 171-
31 Dec, 161-
30 Sep, 16--
30 Jun, 16--100.00%
31 Mar, 161-
31 Dec, 15--

29 institutional shareholders have increased their position in PRME stock as of 31 Mar 23 compared to - in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 236-
31 Dec, 22--
30 Sep, 19--
30 Jun, 19--100.00%
31 Mar, 191-
31 Dec, 181-
30 Sep, 18--
30 Jun, 18--
31 Mar, 18--
31 Dec, 17--100.00%
30 Sep, 171-
30 Jun, 171-
31 Mar, 17--
31 Dec, 16--100.00%
30 Sep, 161-
30 Jun, 16--
31 Mar, 16--
31 Dec, 15--

6 institutional shareholders have reduced their position in PRME stock as of 31 Mar 23 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 237312.31%41,738,5751.01%100.00%-29-6-
31 Dec, 2265-41,322,385-100.00%-----
30 Sep, 19--100.00%--100.00%----100.00%--
30 Jun, 194-53,03225.62%--2---100.00%
31 Mar, 194-20.00%42,21753.33%----100.00%1-
31 Dec, 18525.00%27,533-47.50%--2100.00%1-
30 Sep, 18433.33%52,447484.11%--1---
30 Jun, 183-8,979-54.07%------
31 Mar, 18350.00%19,5502191.91%------
31 Dec, 172-853-92.71%------100.00%
30 Sep, 172-33.33%11,697-15.94%----100.00%1-
30 Jun, 17350.00%13,915-38.54%--1-1-
31 Mar, 172-60.00%22,640-66.62%--1---
31 Dec, 16525.00%67,833114.69%--1---100.00%
30 Sep, 164-31,5969.49%----1-
30 Jun, 16433.33%28,85882.95%----100.00%--
31 Mar, 16350.00%15,77421.15%--1---
31 Dec, 152-13,020-------

Prime Medicine Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 07, 2024Gottesdiener Keith Michaeldirector, officer See RemarksG-GiftSell250,000--2,310,837

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 14, 2024Marrazzo Jeffrey Ddirector-A-AwardBuy45,000$7.68$345.60K45,000
Jun 14, 2024Schenkein David Pdirector-A-AwardBuy45,000$7.68$345.60K45,000
Jun 14, 2024NELSEN ROBERTdirector, 10 percent owner A-AwardBuy45,000$7.68$345.60K45,000
Jun 14, 2024Kelly Michael Aarondirector-A-AwardBuy45,000$7.68$345.60K45,000
Jun 14, 2024Foster-Cheek Kaye Idirector-A-AwardBuy45,000$7.68$345.60K45,000
Jun 14, 2024Chung Wendydirector-A-AwardBuy45,000$7.68$345.60K45,000
Jun 14, 2024Cahill Thomasdirector-A-AwardBuy45,000$7.68$345.60K45,000
Jun 07, 2024Gottesdiener Keith Michaeldirector, officer See RemarksG-GiftSell250,000--2,310,837
Jun 07, 2024Gottesdiener Keith Michaeldirector, officer See RemarksG-GiftBuy250,000--277,166
May 21, 2024Reine Allanofficer Chief Financial OfficerA-AwardBuy100,000$6.80$680.00K100,000
May 21, 2024Brudnick Richardofficer Chief Business OfficerA-AwardBuy19,300$7.96$153.63K38,600
May 21, 2024LEE ANN L.officer Chief Technical OfficerA-AwardBuy80,416$3.67$295.13K160,832
Mar 04, 2024Marrazzo Jeffrey Ddirector-A-AwardBuy250,000$8.63$2.16M250,000
Feb 29, 2024GV 2023 GP, L.L.C.other Member of 10% GroupBuy---3,200,000
Feb 27, 2024Gottesdiener Keith Michaeldirector, officer See RemarksA-AwardBuy100,000$8.32$832.00K100,000
Feb 23, 2024Brudnick Richardofficer Chief Business OfficerA-AwardBuy135,747$8.49$1.15M135,747
Feb 23, 2024Duffield Jeremyofficer Chief Scientific OfficerA-AwardBuy180,995$8.49$1.54M180,995
Feb 23, 2024LEE ANN L.officer Chief Technical OfficerA-AwardBuy180,995$8.49$1.54M180,995
Feb 23, 2024Goldwasser Meredithofficer SVP, Strategy & Corporate Ops.A-AwardBuy90,498$8.49$768.33K90,498
Feb 23, 2024Alenson Carmanofficer See RemarksA-AwardBuy90,498$8.49$768.33K90,498

The last insider sell of Prime Medicine's stock was made by Gottesdiener Keith Michael on Jun 07 2024, selling 250,000 shares at - per share (valued at -).

Prime Medicine Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20241111100.00%
Q1 202411--
Q4 2023-2-
Q3 2023-2-
Q2 202395516.36%
Q1 20236--
Q4 2022192190.48%

11 total buy trades, and 1 total sell trades (buy/sell ratio of 11.00%) were made by Prime Medicine's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024---
Q1 20243--
Q4 2023---
Q3 2023---
Q2 2023-33-
Q1 2023---
Q4 20224--

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Prime Medicine's stocks.

Prime Medicine Peer Ownership


TickerCompany
SANASana Biotechnology, Inc.
DNAGinkgo Bioworks Holdings, Inc.
CRSPCRISPR Therapeutics AG
BPMCBlueprint Medicines Corporation
RPHMReneo Pharmaceuticals, Inc.
IPSCCentury Therapeutics, Inc.
NTLAIntellia Therapeutics, Inc.
EDITEditas Medicine, Inc.
VERVVerve Therapeutics, Inc.
RLAYRelay Therapeutics, Inc.
CRBUCaribou Biosciences, Inc.
RPRXRoyalty Pharma plc
OCEAOcean Biomedical, Inc.
BEAMBeam Therapeutics Inc.
LIFEaTyr Pharma, Inc.

PRME Ownership FAQ


Prime Medicine is owned by institutional shareholders (100.00%), insiders (26.12%), and public (-26.12%). The largest institutional shareholder of Prime Medicine is ALPHABET INC. (39.20% of total shares) and the top mutual fund owner is Kelly Strategic ETF Trust (0.79% of total shares).

Prime Medicine's major institutional shareholders are ALPHABET INC., FMR LLC, REDMILE GROUP, LLC, ARK INVESTMENT MANAGEMENT LLC, and MWG MANAGEMENT LTD.. The top five shareholders own together 81.30% of the company's share outstanding.

As of Mar 2023, there are 73 institutional shareholders of Prime Medicine.

ALPHABET INC owns 13.28M shares of Prime Medicine, representing 39.20% of the company's total shares outstanding, valued at $163.4B (as of Mar 2023).

As of Mar 2023, FMR LLC holds 8.52M shares of Prime Medicine (PRME), compromising 25.13% of the company, valued at $104.76B.

REDMILE GROUP, LLC is the third largest holder of Prime Medicine. The company owns 1.99M of the company's shares outstanding (worth $24.51B).